Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic β-cells

Diabetes

Volumn 49, Issue 7, 2000, Pages 1137-1141

  Seissler, Jochen ^a   Nguyen, Thi Bang Tam ^a   Aust, Gabriela ^b   Steinbrenner, Holger ^a   Scherbaum, Werner A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AUTOANTIGEN; CYCLIC AMP; FORSKOLIN; GLUCAGON; GLUCOSE; ISOBUTYLMETHYLXANTHINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; DOSE RESPONSE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0033948498     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.7.1137     Document Type: Article

References (36)

1. Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514, 1994
2. Rabin DU, Pleasic SM, Shapiro JA, Yoo WH, Oles J, Hicks JM, Goldstein DE, Rae PM: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
3. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511, 1995
4. Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA: Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 41:891-897, 1998
5. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Boehm BO, Richter W: Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 46:565-571, 1997
6. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
7. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie MR, Scherbaum WA, DENIS Study Group: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356, 1996
8. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
9. Durinovic BI, Hummel M, Ziegler AG: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45:795-800, 1996
10. Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, She JX, Notkins AL, Maclaren NK, Atkinson MA: The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 47:566-569, 1998
11. Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schröder S, Seissler J, Scherbaum WA, Kalbacher H: T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. Exp Clin Endocrinol Diabetes 107:166-171, 1999
12. Solimena M, Dirkx R, Hermel JM, Pleasic WS, Shapiro JA, Caron L, Rabin DU: ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15:2102-2114, 1990
13. Notkins AL, Lan MS, Leslie RD: IA-2 and IA-2beta: the immune response in IDDM. Diabetes Metab Rev 14:85-93, 1998
14. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB: Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178, 1992
15. Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, Lotz O, Scherbaum WA, Dralle H, Hoang-Vu C: CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res 57:1798-1806, 1997
16. Platzer C, Ode-Hakim S, Reinke P, Docke WD, Ewert R, Volk HD: Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 58:264-268, 1994
17. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL: Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172:789-794, 1990
18. Sharp GWG: The adenylate cyclase-cyclic AMP system in islet of Langerhans and its role in the control of insulin release. Diabetologia 16:287-296, 1979
19. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248, 1987
20. Hii CS, Jones PM, Persaud SJ, Howell SL: A re-assessment of the role of protein kinase C in glucose-stimulated insulin secretion. Biochem J 246:489-493, 1987
21. Wollheim CB, Regazzi R: Protein kinase C in insulin releasing cells: putative role in stimulus secretion coupling. FEBS Lett 268:376-380, 1990
22. Lester LB, Langeberg LK, Scott JD: Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA 94:14942-14947, 1997
23. Xie J, Zhang B, Lan MS, Notkins AL: Genomic structure and promoter sequence of the insulin-dependent diabetes mellitus autoantigen, IA-2 (PTPRN). Genomics 54:338-343, 1998
24. Della FM, Servillo G, Sassone CP: Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM. FEBS Lett 1410:22-24, 1997
25. Tamai KT, Monaco L, Nantel F, Zazopoulos E, Sassone CP: Coupling signalling pathways to transcriptional control: nuclear factors responsive to cAMP. Recent Prog Horm Res 52:121-139, 1997
26. Thorens B, Deriaz N, Bosco D, DeVos A, Pipeleers D, Schuit F, Meda P, Porret A: Protein kinase A-dependent phosphorylation of GLUT2 in pancreatic beta cells. J Biol Chem 271:8075-8081, 1996
27. Arkhammar P, Nilsson T, Welsh M, Welsh N, Berggren PO: Effects of protein kinase C activation on the regulation of the stimulus-secretion coupling in pancreatic beta-cells. Biochem J 264:207-215, 1989
28. Zawalich WS, Zawalich KC, Ganesan S, Calle R, Rasmussen H: Effects of the phorbol ester phorbol 12-myristate 13-acetate (PMA) on islet-cell responsiveness. Biochem J 278:49-56, 1991
29. + channel independent mechanisms: role of phospholipase C. Am J Physiol 272:E671-E677, 1997
30. Liu JP: Protein kinase C and its substrates. Mol Cell Endocrinol 116:1-29, 1996
31. Brun T, Roche E, Kim KH, Prentki M: Glucose regulates acetyl-CoA carboxylase gene expression in a pancreatic beta-cell line (INS-1). J Biol Chem 268:18905-18911, 1993
32. Roche E, Assimacopoulos JF, Witters LA, Perruchoud B, Yaney G, Corkey B, Asfari M, Prentki M: Induction by glucose of genes coding for glycolytic enzymes in a pancreatic beta-cell line (INS-1). J Biol Chem 272:3091-3098, 1997
33. Eizirik DL, Korbutt GS, Hellerstrom C: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 90:1263-1268, 1992
34. Ling Z, Kiekens R, Mahler T, Schuit FC, Pipeleers-Marichal M, Sener A, Klöppel G, Malaisse WJ, Pipeleers DG: Effects of chronically elevated glucose levels on the functional properties of rat pancreatic β-cells. Diabetes 45: 1774-1782, 1996
35. Roche E, Farfari S, Witters LA, Assimacopoulos JF, Thumelin S, Brun T, Corkey BE, Saha AK, Prentki M: Long-term exposure of beta-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes 47:1086-1094, 1998
36. Stoker A, Dutta R: Protein tyrosine phosphatases and neural development. Bioessays 20:463-172, 1998